Eva E. Schaake

458 total citations
26 papers, 317 citations indexed

About

Eva E. Schaake is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Eva E. Schaake has authored 26 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Surgery. Recurrent topics in Eva E. Schaake's work include Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (6 papers). Eva E. Schaake is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (7 papers) and Advanced Radiotherapy Techniques (6 papers). Eva E. Schaake collaborates with scholars based in Netherlands, Germany and Belgium. Eva E. Schaake's co-authors include Jacobus A. Burgers, Renée van Pel, Houke M. Klomp, Renato A. Valdés Olmos, Harm van Tinteren, Hendrik J. Teertstra, Henk Codrington, Ingrid Kappers, Jan‐Jakob Sonke and Wieneke A. Buikhuisen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Eva E. Schaake

23 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva E. Schaake Netherlands 12 208 117 91 61 59 26 317
Alice Zamagni Italy 9 121 0.6× 69 0.6× 96 1.1× 69 1.1× 68 1.2× 40 271
B. Pilecki Poland 8 248 1.2× 98 0.8× 117 1.3× 95 1.6× 126 2.1× 31 410
Steffen Hennies Germany 13 191 0.9× 81 0.7× 162 1.8× 89 1.5× 174 2.9× 15 365
Chiara Lucrezia Deantoni Italy 9 173 0.8× 83 0.7× 49 0.5× 119 2.0× 49 0.8× 29 273
Melissa A.L. Vyfhuis United States 10 201 1.0× 60 0.5× 182 2.0× 89 1.5× 35 0.6× 30 390
C.S. Thorpe United States 8 94 0.5× 51 0.4× 75 0.8× 47 0.8× 57 1.0× 32 257
Takashi Shintani Japan 13 241 1.2× 186 1.6× 103 1.1× 105 1.7× 38 0.6× 32 363
A.R. Alitto Italy 10 127 0.6× 97 0.8× 44 0.5× 92 1.5× 28 0.5× 31 228
C. Chiumento Italy 11 148 0.7× 107 0.9× 38 0.4× 123 2.0× 52 0.9× 27 285
Thomas Zusag United States 11 153 0.7× 58 0.5× 88 1.0× 98 1.6× 86 1.5× 26 307

Countries citing papers authored by Eva E. Schaake

Since Specialization
Citations

This map shows the geographic impact of Eva E. Schaake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva E. Schaake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva E. Schaake more than expected).

Fields of papers citing papers by Eva E. Schaake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva E. Schaake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva E. Schaake. The network helps show where Eva E. Schaake may publish in the future.

Co-authorship network of co-authors of Eva E. Schaake

This figure shows the co-authorship network connecting the top 25 collaborators of Eva E. Schaake. A scholar is included among the top collaborators of Eva E. Schaake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva E. Schaake. Eva E. Schaake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Amant, Frédéric, et al.. (2024). Primary chemoradiation versus neoadjuvant chemotherapy followed by surgery as treatment strategy for locally advanced vulvar carcinoma (VULCANize2). International Journal of Gynecological Cancer. 34(10). 1639–1642. 1 indexed citations
3.
Rijkmans, E.C., et al.. (2024). Evaluation of deep learning-based target auto-segmentation for Magnetic Resonance Imaging-guided cervix brachytherapy. Physics and Imaging in Radiation Oncology. 32. 100669–100669.
4.
Barros, Hilda A. de, Maarten L. Donswijk, Eva E. Schaake, et al.. (2023). The Diagnostic Value of the Sentinel Node Procedure to Detect Occult Lymph Node Metastases in PSMA PET/CT Node–Negative Prostate Cancer Patients. Journal of Nuclear Medicine. 64(10). 1563–1566. 1 indexed citations
5.
Schaake, Eva E., et al.. (2023). Deep learning for segmentation of the cervical cancer gross tumor volume on magnetic resonance imaging for brachytherapy. Radiation Oncology. 18(1). 91–91. 15 indexed citations
6.
Barros, Hilda A. de, Daan Mulder, Vincent van der Noort, et al.. (2023). Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy. European Urology Open Science. 49. 80–89. 11 indexed citations
7.
Schaake, Eva E., et al.. (2023). A network score-based metric to optimize the quality assurance of automatic radiotherapy target segmentations. Physics and Imaging in Radiation Oncology. 28. 100500–100500. 9 indexed citations
8.
Boellaard, Thierry N., Joost L. Boormans, Richard P. Meijer, et al.. (2023). Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial. Frontiers in Oncology. 13. 1246603–1246603. 3 indexed citations
10.
Vries, Hielke M. de, Sarah R. Ottenhof, Erik van Werkhoven, et al.. (2022). Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile Cancer. European Urology Open Science. 47. 29–35.
11.
Mens, Jan Willem, Friederike Koppe, Ina M. Jürgenliemk‐Schulz, et al.. (2021). Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: Implications for shared decision making. Gynecologic Oncology. 161(3). 727–733. 3 indexed citations
12.
Deijen, Charlotte L., Eva E. Schaake, Wouter V. Vogel, et al.. (2021). PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer. Clinical and Translational Radiation Oncology. 30. 1–6. 15 indexed citations
13.
Voskuilen, Charlotte S., Laura S. Mertens, Marinus A. Noordzij, et al.. (2020). Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil. Radiotherapy and Oncology. 150. 275–280. 9 indexed citations
15.
Donswijk, Maarten L., et al.. (2020). Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer. Clinical and Translational Radiation Oncology. 22. 9–14. 6 indexed citations
16.
Schaake, Eva E., Maddalena Rossi, Wieneke A. Buikhuisen, et al.. (2014). Differential Motion Between Mediastinal Lymph Nodes and Primary Tumor in Radically Irradiated Lung Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 90(4). 959–966. 35 indexed citations
18.
Schaake, Eva E., Ingrid Kappers, Henk Codrington, et al.. (2012). Tumor Response and Toxicity of Neoadjuvant Erlotinib in Patients With Early-Stage Non–Small-Cell Lung Cancer. Journal of Clinical Oncology. 30(22). 2731–2738. 68 indexed citations
19.
Schaake, Eva E., J. Belderbos, Wieneke A. Buikhuisen, et al.. (2012). Mediastinal lymph node position variability in non-small cell lung cancer patients treated with radical irradiation. Radiotherapy and Oncology. 105(2). 150–154. 15 indexed citations
20.
Richel, Dick J., Casper H.J. van Eijck, Joost J. Nuyttens, et al.. (2010). Phase II trial of Uracil/Tegafur plus leucovorin and celecoxib combined with radiotherapy in locally advanced pancreatic cancer. Radiotherapy and Oncology. 98(2). 261–264. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026